CN101062245A - Chinese traditional medicine agent for treating children nephropathy syndrome - Google Patents
Chinese traditional medicine agent for treating children nephropathy syndrome Download PDFInfo
- Publication number
- CN101062245A CN101062245A CN 200710015854 CN200710015854A CN101062245A CN 101062245 A CN101062245 A CN 101062245A CN 200710015854 CN200710015854 CN 200710015854 CN 200710015854 A CN200710015854 A CN 200710015854A CN 101062245 A CN101062245 A CN 101062245A
- Authority
- CN
- China
- Prior art keywords
- herba
- nephropathy syndrome
- treating children
- root
- children
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicinal composition for treating children's nephropathy which comprises the following raw materials: dried rehmannia root 12g,anemarrhena rhizome 9g, yellow-corktree bark 6g,root bark of tree peony 9g, astragalus root 15g,pseudostellaria root 9g, poria cocos wolf 12g, Chinese yam 12g and oldenlandia 15g.
Description
Technical field
The present invention relates to a kind of Chinese medicinal formulae for the treatment of children nephropathy syndrome of field of traditional Chinese.
Background technology
The medicine of the treatment nephrotic syndrome contains hormone mostly at present, uses hormone meeting serious harm juvenile's human body health in a large number, for a long time.
Summary of the invention
Purpose of the present invention is exactly the defective that exists at prior art, and a kind of pure Chinese medicine that does not contain hormone is provided, and the Chinese medicinal formulae of the treatment children nephropathy syndrome that can be used in existing hormonotherapy.
Its technical scheme is: comprise following raw materials according in every dose of prescription and form: Radix Rehmanniae 12g, Rhizoma Anemarrhenae 9g, Cortex Phellodendri 6g, Cortex Moutan 9g, Radix Astragali 15g, Radix Pseudostellariae 9g, Poria 12g, Rhizoma dioscoreae 12g, Herba Damnacanthi 10g, Herba Hedyotidis Diffusae 15g.
Also comprise following raw materials according in the above-mentioned prescription: Herba Epimedii 9g, Semen Cuscutae 12g, Herba Cistanches 9g.
The present invention has heat-clearing and toxic substances removing, the effect of benefiting qi and nourishing yin.The Radix Astragali, the Rhizoma Anemarrhenae, Cortex Phellodendri, Cortex Moutan, Poria, Herba Hedyotidis Diffusae, Herba Damnacanthi heat-clearing and toxic substances removing are inducing diuresis and reducing edema in the side, and the main master of liter goes out main opening, and the interior stasis of blood poison that clears away the dampness and heat can be resisted the invasion of exopathogen outward, reaches the purpose of eliminating pathogenic factor for supporting vital QI; The Radix Rehmanniae, Radix Pseudostellariae, Rhizoma dioscoreae removing heat from blood supplementing QI and nourishing YIN, the master falls main becoming owner of and closes, and the interior healthy energy that excites is got rid of evils and is gone out, but outer benefiting QI for strengthening the superficies is resisted exopathogen.The effect that full side plays heat-clearing and toxic substances removing, benefiting qi and nourishing yin altogether.Modern pharmacological research thinks that the Radix Rehmanniae has hormone-like effect, but the side effect of unrestraint adrenal cortex function; Rhizoma Anemarrhenae antiinflammatory action and prednisone are close, and have the effect that reduces plasma cholesterol; The Radix Astragali, Radix Pseudostellariae, Rhizoma dioscoreae can strengthen the phagocytic function of reticuloendothelial system, improve the ratio of CD4/CD8, but enhancing human body immunity power; Herba Damnacanthi, Herba Hedyotidis Diffusae have the effect of adjusting immunity of organism.Originally can reduce hormone side effect, improve frequently relapsing nephrotic syndrome infant immunity, thereby reduce infection chance, reduce recurrent number, and the smooth decrement of hormone be played the effect of transition.
The specific embodiment
Radix Rehmanniae 12g, Rhizoma Anemarrhenae 9g, Cortex Phellodendri 6g, Cortex Moutan 9g, Radix Astragali 15g, Radix Pseudostellariae 9g, Poria 12g, Rhizoma dioscoreae 12g, Herba Damnacanthi 10g, Herba Hedyotidis Diffusae 15g.
Usage: add water 400ml, the dense 200ml that fries in shallow oil, 100ml/ time, 2 times on the 1st.
Clinical practice: in heavy dose of hormone application stage, infant shows resembling of hyperactivity of YANG due to deficiency of YIN, cooperates this prescription to the prevention Cushing's syndrome, and reducing hormone side effect has effect preferably; In the hormone decrement stage, infant shows resembling of yang deficiency, can add the product of the kidney invigorating warming YANG, and as Herba Epimedii 9g, Semen Cuscutae 12g, Herba Cistanches 9g etc., the Heibei provincial opera negative and positive make YIN and YANG in a relative equilibrium, the body rehabilitation.
Claims (2)
1, a kind of Chinese medicinal formulae for the treatment of children nephropathy syndrome is characterized in that comprising in every dose of prescription following raw materials according and forms: Radix Rehmanniae 12g, Rhizoma Anemarrhenae 9g, Cortex Phellodendri 6g, Cortex Moutan 9g, Radix Astragali 15g, Radix Pseudostellariae 9g, Poria 12g, Rhizoma dioscoreae 12g, Herba Damnacanthi 10g, Herba Hedyotidis Diffusae 15g.
2, the Chinese medicinal formulae of treatment children nephropathy syndrome according to claim 1 is characterized in that also comprising in every dose of prescription following raw materials according: Herba Epimedii 9g, Semen Cuscutae 12g, Herba Cistanches 9g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710015854 CN101062245A (en) | 2007-06-07 | 2007-06-07 | Chinese traditional medicine agent for treating children nephropathy syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710015854 CN101062245A (en) | 2007-06-07 | 2007-06-07 | Chinese traditional medicine agent for treating children nephropathy syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101062245A true CN101062245A (en) | 2007-10-31 |
Family
ID=38963660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200710015854 Pending CN101062245A (en) | 2007-06-07 | 2007-06-07 | Chinese traditional medicine agent for treating children nephropathy syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101062245A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104208427A (en) * | 2014-09-16 | 2014-12-17 | 青岛华仁技术孵化器有限公司 | Pharmaceutical preparation for treating nephritic syndrome and preparation method thereof |
CN105770746A (en) * | 2016-04-12 | 2016-07-20 | 佛山市朗达信息科技有限公司 | Bathing composition capable of achieving immune function regulation for external use and preparing method thereof |
CN106491909A (en) * | 2017-01-11 | 2017-03-15 | 吉林大学 | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome |
-
2007
- 2007-06-07 CN CN 200710015854 patent/CN101062245A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104208427A (en) * | 2014-09-16 | 2014-12-17 | 青岛华仁技术孵化器有限公司 | Pharmaceutical preparation for treating nephritic syndrome and preparation method thereof |
CN105770746A (en) * | 2016-04-12 | 2016-07-20 | 佛山市朗达信息科技有限公司 | Bathing composition capable of achieving immune function regulation for external use and preparing method thereof |
CN106491909A (en) * | 2017-01-11 | 2017-03-15 | 吉林大学 | A kind of Chinese medicine for treating Childhood Nephrotic Syndrome |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1114435C (en) | Ganlu pill and its preparing process | |
CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
CN101195022A (en) | Chinese medicine prescription for curing tumor | |
CN1279073A (en) | Antisenility Chinese medicine | |
CN101195001A (en) | Chinese medicine prescription for treating hypertension, hypercholesterolemia and hyperglycemia | |
CN1286490C (en) | anti inflammation decoction for treating morbid leucorrhea, etc. | |
CN103405704B (en) | Stomach medicine and production method thereof | |
CN101049490A (en) | Herb water of angelica and Chinese mugwort leaves | |
CN101670089A (en) | Traditional Chinese medicine for treating acute gastroenteritis | |
CN100431583C (en) | A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same | |
CN101062245A (en) | Chinese traditional medicine agent for treating children nephropathy syndrome | |
CN101062212A (en) | Chinese medicinal herb composition for treating gastritis | |
CN103656122A (en) | Traditional Chinese medicine for treating externally-contracted heat disease and preparation method thereof | |
CN101062259A (en) | Lily bolus for clearing lung heat | |
CN101129967A (en) | Traditional Chinese medicine for treating diabetes diarrhea | |
CN1140291C (en) | Stone-eliminating Jinyin medicine powder | |
CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
CN101062397A (en) | Angelica medicine liquid for treating frostbite | |
CN101130003A (en) | Traditional Chinese medicine for treating acute cholecystitis | |
CN101856488A (en) | Chinese medicament for treating tracheitis | |
CN101062228A (en) | Decoction for removing speckle and for enriching yin and draining fire | |
CN101062248A (en) | Radix rehmanniae tuckahoe oral liquid | |
CN101062236A (en) | Astragalus radix pseudostell oral liquid | |
CN105687474A (en) | Preparation for cancer patient to take during chemotherapy period and preparation method | |
CN101138604A (en) | Chinese medicine for treating intractable cough |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |